Vitamin D supplements may not curb breast cancer rates

07/31/2013 | DailyRx.com

An Italian meta-analysis of nearly 6,500 people showed that those who took vitamin D3 supplements were no less likely to develop breast cancer than the placebo group. Although the supplementation was not associated with lower breast cancer incidence, senior study author Antonio Giordano said research on the topic is not yet adequate enough to draw firm conclusions. The findings appear in the journal PLOS ONE.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX